BioMarin to Participate in Upcoming Virtual Investor Conference

 

SAN RAFAEL, Calif., Sept. 29, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer, will participate in Morningstar's Management Behind the Moat Conference on September 30, 2020 at 1:00pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:

 

Investors   

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-virtual-investor-conference-301139652.html

SOURCE BioMarin Pharmaceutical Inc.

 
 
Company Codes: NASDAQ-NMS:BMRN
 

Back to news